Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An invasive malignant neoplasm that arises from the ovary and is characterized by the presence of malignant epithelial cells that contain intracytoplasmic mucin and may resemble the epithelial cells of the endocervix or gastrointestinal tract. It includes mucinous adenocarcinoma and mucinous adenocarcinofibroma.
Biomarker and diagnostic research for mucinous ovarian cancer has been reported in the published literature.
2 clinical trials registered, 1 recruiting. Interventions under study include drug therapy and other interventions. Pipeline includes 2 PHASE2. Research is primarily sponsored by academic and government institutions.
182 publications have been identified in PubMed for mucinous ovarian cancer. Research spans Basic Science / Preclinical (37%), Review / Meta-Analysis (15%), and Epidemiology / Natural History (13%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 67 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 9:42 PM UTC
Research summaries | 28 | 15% |
Disease patterns and progression | 24 | 13% |
Testing and diagnosis research | 22 | 12% |
Patient case studies | 18 | 10% |
New treatment approaches | 15 | 8% |
Clinical study results | 8 | 4% |
Liu P (2026). [PMID: 41455287](https://pubmed.ncbi.nlm.nih.gov/41455287/). *Eur J Surg Oncol*. [Epidemiology / Natural History]
Sun Y (2026). [PMID: 41887053](https://pubmed.ncbi.nlm.nih.gov/41887053/). *Pathol Res Pract*. [Case Report / Case Series]
Cavarzerani E (2026). [PMID: 40783069](https://pubmed.ncbi.nlm.nih.gov/40783069/). *J Adv Res*. [Basic Science / Preclinical]
De Boeck A (2026). [PMID: 40970686](https://pubmed.ncbi.nlm.nih.gov/40970686/). *Histopathology*. [Basic Science / Preclinical]
Pieraccioli M (2026). [PMID: 41520487](https://pubmed.ncbi.nlm.nih.gov/41520487/). *Drug Resist Updat*. [Basic Science / Preclinical]
Sandrasegaran K (2026). [PMID: 40748460](https://pubmed.ncbi.nlm.nih.gov/40748460/). *Abdominal radiology (New York)*. [Review / Meta-Analysis]
Bartl T (2026). [PMID: 41680018](https://pubmed.ncbi.nlm.nih.gov/41680018/). *International journal of gynecological cancer : official journal of the International Gynecological Cancer Society*. [Clinical Trial Publication]
Araki H (2026). [PMID: 41461380](https://pubmed.ncbi.nlm.nih.gov/41461380/). *The journal of obstetrics and gynaecology research*. [Diagnostic / Biomarker]
Hattori M (2026). [PMID: 41520625](https://pubmed.ncbi.nlm.nih.gov/41520625/). *Clin Radiol*. [Diagnostic / Biomarker]
Pundel OJ (2026). [PMID: 41052931](https://pubmed.ncbi.nlm.nih.gov/41052931/). *Cold Spring Harb Perspect Med*. [Review / Meta-Analysis]